Braun J, Sörgel F, Gluth W P, Oie S
Institute of Nephrology, University of Erlangen-Nürnberg, FRG.
Eur J Clin Pharmacol. 1987;32(6):625-9. doi: 10.1007/BF02456000.
The pharmacokinetics of disopyramide were determined in 10 healthy volunteers after a 300 mg oral dose and again after a 2 mg/kg i.v. dose. The unbound clearance was 599 ml/min and the unbound renal clearance 310 ml/min. The terminal elimination rate constant of unbound drug was 0.180 h-1 after the i.v. dose and 0.203 h-1 after the oral dose. The absorption rate constant was 0.53(-1) and the maximum peak concentration occurred after 3.2 h. The bioavailability was 0.809 using the area under the unbound plasma concentration time curve. Although a saturable plasma protein binding was found in all subjects the bioavailability using the total concentration, in contrast to theoretical expectations, showed the same value (0.813) as the unbound concentrations.
在10名健康志愿者中测定了口服300毫克剂量后及静脉注射2毫克/千克剂量后丙吡胺的药代动力学。非结合清除率为599毫升/分钟,非结合肾清除率为310毫升/分钟。静脉注射剂量后非结合药物的终末消除速率常数为0.180小时-1,口服剂量后为0.203小时-1。吸收速率常数为0.53(-1),最大峰浓度出现在3.2小时后。使用非结合血浆浓度-时间曲线下面积计算的生物利用度为0.809。尽管在所有受试者中均发现了可饱和的血浆蛋白结合,但与理论预期相反,使用总浓度计算的生物利用度与非结合浓度显示相同的值(0.813)。